These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19047265)

  • 21. Endoscopic sedation in pediatric practice.
    Fredette ME; Lightdale JR
    Gastrointest Endosc Clin N Am; 2008 Oct; 18(4):739-51, ix. PubMed ID: 18922412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How many claudicants should be prescribed statins?
    Harrison EM; Holdsworth RJ
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
    [No Abstract]   [Full Text] [Related]  

  • 23. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
    Lubsen J
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
    [No Abstract]   [Full Text] [Related]  

  • 24. When should young people with chronic rheumatic disease move from paediatric to adult-centred care?
    Robertson L
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):387-97. PubMed ID: 16546063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance: practice guidelines and attitude changes.
    Kozma CM
    Manag Care Interface; 2001 Apr; 14(4):66-7. PubMed ID: 11339024
    [No Abstract]   [Full Text] [Related]  

  • 26. Need for change in implementation of paediatric regulation.
    Vassal G; Blanc P; Pearson A
    Lancet Oncol; 2013 Nov; 14(12):1156-7. PubMed ID: 24176557
    [No Abstract]   [Full Text] [Related]  

  • 27. Maintenance of Certification: the role of the American Board of Pediatrics in improving children's health care.
    Miles PV
    Pediatr Clin North Am; 2009 Aug; 56(4):987-94. PubMed ID: 19660640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice parameters: a foundation for quality advancement.
    Kelly JT; Swartwout JE
    AAPPO J; 1991; 1(1):33-8. PubMed ID: 10148894
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention: providing lipid management in a large clinical practice.
    Brown AS
    Manag Care; 2003 Sep; 12(9 Suppl):16-21. PubMed ID: 14535131
    [No Abstract]   [Full Text] [Related]  

  • 31. [JUPITER study (2). For now no reason to give statins to more people].
    Koopmans RP
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):218-9. PubMed ID: 19271439
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pediatric resuscitation. Current guidelines and treatment recommendations].
    Francis RC; Höhne C; Proquitté H; Kerner T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Jan; 43(1):8-17; quiz 18. PubMed ID: 18196487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Special recommendations for lipid-lowering treatment: efficacy and safety].
    Martinez TL; Nascimento HM
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():6-8. PubMed ID: 16400389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost and effectiveness of cardiovascular prevention.
    Boyar A
    Am J Cardiol; 2007 Nov; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815
    [No Abstract]   [Full Text] [Related]  

  • 35. Guideline statement: management of procedure-related pain in children and adolescents.
    J Paediatr Child Health; 2006 Feb; 42 Suppl 1():S1-29. PubMed ID: 16626312
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of guidelines for determining frequency of therapy services in a pediatric medical setting.
    Bailes AF; Reder R; Burch C
    Pediatr Phys Ther; 2008; 20(2):194-8. PubMed ID: 18480720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In response to Dr. McCormick (2002;1:179-180).
    Polgár C; Major T; Fodor J
    Brachytherapy; 2003; 2(2):117-8; author reply 118. PubMed ID: 15062151
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The limits of immune investigations in pediatric practice].
    Blanc A; Suez D; Saglier P; Guran P
    Ann Pediatr (Paris); 1978 Oct; 25(8):393-6. PubMed ID: 16114351
    [No Abstract]   [Full Text] [Related]  

  • 40. Daring to practice low-cost medicine in a high-tech era.
    Palfrey S
    N Engl J Med; 2011 Mar; 364(11):e21. PubMed ID: 21366468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.